FEDERALUnknownLow
ENANTA PHARMACEUTICALS INC
bd_778db8c2cb6d31a8 · schema v1 · pii pii-v1
Full breach record for ENANTA PHARMACEUTICALS INC →SEC 10-K Item 1C disclosure describing the registrant's general cybersecurity risk management and strategy program (NIST framework, vISO, IRP, penetration testing, phishing simulations, cyber insurance, Audit Committee oversight). The filing affirmatively states the environment contains no known risks from cybersecurity threats that could materially impact operations, financials, or reputation. No specific cybersecurity incident is disclosed.
Tracked as a single-filing incident — the only disclosure on record for this event so far.ConfirmedView incident
Source provenance
- Source URL
- https://www.sec.gov/Archives/edgar/data/1177648/000095017024131260/enta-20240930.htm
DisclosureLens renders the full SEC/HHS filing inline below from the originating regulator’s public record (§4.5 fair report privilege).
- Filed at
- Nov 27, 2024
- Raw hash
- 5ebd85fcaf37ec1fed99382938739f2ac3fe2860aaeebb976cc09988c28eadab
Source filing
AI-assisted summary above. The structured extract on this page was generated from the document below. Inspect the source to verify or correct any field.
Reporting entity
- Name
- ENANTA PHARMACEUTICALS INCnorm: enanta pharmaceuticals
- SEC CIK
- 1177648
Victim entity
- Name
- ENANTA PHARMACEUTICALS INCnorm: enanta pharmaceuticals
- SEC CIK
- 1177648
Incident
- Discovered
- —
- Materiality determined
- —
- Notification sent
- —
- Affected individuals
- Not disclosed
- Data types
- —
- Attack vector
- Unknown
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.